How Safe and Effective is Micropulse Transscleral Cyclophotocoagulation in Patients With Uncontrolled Glaucoma?

Completed · Not applicable

Conditions studied: Glaucoma

In brief

The purpose of this study is to investigate the surgical outcomes of the micropulse transscleral cyclophotocoagulation (mTSCPC) in patients with uncontrolled glaucoma; analyze intraocular pressure lowering effect; and correlate related treatment parameters pending enrollment of sufficient numbers of dark pigmented versus light pigmented eyes.

Key facts

Study ID

NCT02627352

Run by

Wills Eye

People needed

15

Starts

2014-02-01

Expected to finish

2017-08-01

Last updated by the study team

2017-10-11

Who can join

Age: 20 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Age ≤ 20 years old.
• Patients who had undergone previous intraocular surgery or ocular laser treatment within 2 months of enrolment.
• Patients who had undergone previous conventional continuous wave mode TSCPC within 1 months of enrolment.
• Patients with significant scleral thinning as defined by greater than 1 clock hour.
• Patients with any medical condition that would preclude the subject from providing informed consent or reliable and valid data.
• Patients enrolled in other prospective clinical trials.
• Albino patients that have no pigmentation

Where it is running

• Wills Eye Institute, Glaucoma Service — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.